CHAPTERS Group AG

CHAPTERS Group AG raises EUR 52m of funding commitments at EUR 24.70 per share for intended Capital Increase with Rights Issue in 2024

CHAPTERS Group AG: Backstop-Agreement concluded with a group of institutional investors

CHAPTERS Group AG announces the result of the Buyback offer for the 2020 bond

Buyback offer for up to EUR 9 million nominal amount of the 2020 bond

CHAPTERS Group AG finishes successful 2023 financial year; Strong momentum continues in 2024

Extension of Marlene Carl’s Management Board contract and Jan-Hendrik Mohr’s parental leave

Capital Increase against contribution in kind from Authorized Capital resolved

CHAPTERS Group AG: Capital Increase against contribution in kind from Authorized Capital resolved

CHAPTERS Group AG: Marlene Carl, Kauf

CHAPTERS Group AG: Marlene Carl, Kauf

Raising of Additional Equity to Drive Acceleration of Growth

CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 23, 2023

CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved

CHAPTERS Group AG: 2023 Interim Report Shows Strong Growth in the First Half of the Year

CHAPTERS Group AG: Management buy-out of the property services group of NGC Nachfolgekapital GmbH

CHAPTERS Group AG: Management buy-out of the property services group of NGC Nachfolgekapital GmbH

CHAPTERS Group AG: Jan-Hendrik Mohr, Erhalt von 25.782 Aktien als Performance Fee aus der Beendigung eines Anlageberatungsvertrags

CHAPTERS Group AG: MSA Capital GmbH, Erhalt von 25.778 Aktien als Performance Fee aus der Beendigung eines Anlageberatungsvertrags

Officially Starting the Next CHAPTER

MEDIQON Group AG: Expansion of Capital Base to Accelerate Growth

MEDIQON Group AG: Privatplatzierung der am 25.05.2023 beschlossenen Barkapitalerhöhung aus genehmigtem Kapital erfolgreich abgeschlossen

MEDIQON Group AG: Durchführung einer Barkapitalerhöhung aus genehmigtem Kapital und erneute Platzierung der Ewigkeitsanleihe 2020 beschlossen sowie Verpflichtung zum Rückkauf der Anleihe 2020

MEDIQON Group AG: 2022 Annual Report – Strong Operating Performance and Continued Success with Acquisitions – Renaming and New Board Director Proposed at AGM to Embark on Next Chapter of Growth

MEDIQON Group AG: Annual Report for the 2022 financial year published

MEDIQON Group AG: Jan-Hendrik Mohr, Kauf

MEDIQON Group AG: Jan-Hendrik Mohr, Kauf

MEDIQON Group AG: Group growth continued again in the 2022 financial year and a successful start to the 2023 financial year

MEDIQON Group AG: Executive Board contract of Jan-Hendrik Mohr extended

MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth

MEDIQON Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on December 12, 2022